$4,301.22 travel Payment -- Sanofi to Dr. Eric Sanchez

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Sanofi made a $4.3K travel payment to Eric Sanchez, a Rheumatology specialist in Rochester, NY. The payment was associated with Skyrizi. Sanofi provided $4,301.22 in travel and lodging payments to Dr. Eric Sanchez. The payment was associated with the drug Skyrizi. The payment occurred on August 30, 2024, and was made in Rochester, NY.

Patient Guidance: What This Payment Means for You

This payment may cover travel and lodging expenses related to your doctor's professional activities, potentially including educational events or discussions about medications like Skyrizi. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Travel and lodging payments are common in Rheumatology, often supporting physician education and engagement with pharmaceutical companies regarding treatments like Skyrizi.

Regulatory Context: Sunshine Act Requirements

This payment is subject to reporting under the Physician Payments Sunshine Act, requiring disclosure of transfers of value from manufacturers to physicians.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharmaceutical-payments
• travel-and-lodging
• rheumatology
• drug-promotion
• open-payments
• sanofi
• skyrizi

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $4.3K payment for?

This was a travel payment of $4.3K from Sanofi to Eric Sanchez, categorized as "Travel and Lodging". It was associated with Skyrizi. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Eric Sanchez accept pharmaceutical money?

Yes, Eric Sanchez received this $4.3K payment from Sanofi. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Eric Sanchez's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $4.3K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Rheumatology?

To compare this payment against Rheumatology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Rheumatology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Eric Sanchez's relationship with Sanofi?

The payment covers travel and lodging, indicating potential support for educational events or consultations. This $4.3K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Rheumatology?

The specific drug, Skyrizi, suggests the payment is tied to the promotion or discussion of this particular pharmaceutical.

What should patients do after learning about this payment?

This payment may cover travel and lodging expenses related to your doctor's professional activities, potentially including educational events or discussions about medications like Skyrizi.

What else should I know about this travel payment?

The amount is moderate, suggesting it covers reasonable expenses rather than excessive hospitality.

Related Reports

• View Dr. Eric Sanchez's full payment report
• Sanofi full spending report
• Browse all Rheumatology payments
• Browse all payments in New York
• Search for other payments